Holen Sie sich die Stockscreener-App
98.63
2.31%
-2.33
Vorhandelsmarkt:
99.38
0.75
+0.76%
Irhythm Technologies Inc Aktie (IRTC) Neueste Nachrichten
Holter Monitoring System Market to Reach $1.91 Bn by 2034 | Miniaturization, Telehealth & Patient-Centric Innovations Fuel Growth - Global Banking | Finance | Review
iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025 | IRTC Stock News - GuruFocus
iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025 - The Manila Times
Digital Health Leader iRhythm Technologies Announces Q1 2025 Earnings Release Date - Stock Titan
iRhythm Technologies Announces Third Quarter 2024 Financial Results - ADVFN
iRhythm Technologies Releases 2024 Corporate Sustainability Report That Demonstrates Ongoing Commitment to Culture of Quality and Sustainability | IRTC Stock News - GuruFocus
iRhythm's New Sustainability Report Reveals 89.5% Waste Reduction and Global Market Expansion - Stock Titan
SEC Form DEF 14A filed by iRhythm Technologies Inc. - Quantisnow
Turing Medical names Kevin King as president and CEO - MSN
Turing Medical Names Transformative Med Tech Leader Kevin King as President and Chief Executive Officer - 01net
Turing Medical Taps ex-iRhythm CEO Kevin King as Chief Exec - Medical Product Outsourcing
Turing Medical Names Transformative Med Tech Leader Kevin King a - GuruFocus
iRhythm Technologies (IRTC) Price Target Lowered by Truist Amid Market Uncertainties | IRTC Stock News - GuruFocus
Truist Cuts Price Target on iRhythm Technologies to $120 From $145, Keeps Buy Rating - marketscreener.com
3 Reasons IRTC is Risky and 1 Stock to Buy Instead - Yahoo Finance
Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI) - The Globe and Mail
1 Small-Cap Stock Worth Your Attention and 2 to Question - Yahoo Finance
Cardiac Monitoring Devices Market Trends | Wearable & Remote - openPR.com
iRhythm Technologies, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before April 8, 2024 to Discuss Your Rights – IRTC - ACCESS Newswire
When Will iRhythm Technologies, Inc. (NASDAQ:IRTC) Turn A Profit? - Yahoo
Would iRhythm Technologies (NASDAQ:IRTC) Be Better Off With Less Debt? - simplywall.st
Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks - Yahoo Finance
Press Release Distribution & PR Platform - ACCESS Newswire
Tempus AI Surges 43% YTD: Is It The Right Time To Invest In The Stock? - Barchart.com
Tempus AI Surges 43% YTD: Is it the Right Time to Invest in the Stock? - Yahoo
iRhythm data highlights benefits of Zio long-term heart monitoring - MassDevice
(IRTC) Trading Advice - news.stocktradersdaily.com
iRhythm Unveils New Data Demonstrating Benefits of Long-Term Continuous Monitoring for Arrhythmia Detection - Diagnostic and Interventional Cardiology
New studies challenge efficacy of short-term heart monitors - Investing.com
iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection - TradingView
Major Study Reveals Critical Flaw in Traditional Heart Monitoring: 64% of Arrhythmias Missed - Stock Titan
Commit To Buy iRhythm Technologies At $75, Earn 8.6% Annualized Using Options - Nasdaq
Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against iRhythm Technologies, Inc. - PR Newswire
UPCOMING IRTC DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds iRhythm Technologies, Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
3 Healthcare Stocks in the Doghouse - Yahoo Finance
(IRTC) Trading Signals - news.stocktradersdaily.com
Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers - The Globe and Mail
Tempus AI Surges 40% YTD: Are New Strategic Deals A Buy Signal? - Barchart
BREAKING ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages iRhythm Technologies, Inc. Investors with Large Losses to Secure Counsel Before Important Deadline – IRTC - Business Wire
iRhythm Technologies (IRTC) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
DexCom CGM Sensor Sales to Continue Despite FDA Warning Letter - Yahoo Finance
iRhythm Technologies Inc (IRTC) Shares Gap Down to $83.555 on De - GuruFocus.com
Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD) - Barchart
When the Price of (IRTC) Talks, People Listen - news.stocktradersdaily.com
Shareholders that lost money on iRhythm Technologies, Inc.(IRTC) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Despite currently being unprofitable, iRhythm Technologies (NASDAQ:IRTC) has delivered a 28% return to shareholders over 5 years - Simply Wall St
iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Sold by Principal Financial Group Inc. - Defense World
iRhythm Technologies, Inc. to Host Earnings Call - ACCESS Newswire
iRhythm Technologies, Inc. (NASDAQ:IRTC) Stake Raised by Bank of New York Mellon Corp - Defense World
Unveiling iRhythm Technologies (IRTC)'s Value: Is It Really Pric - GuruFocus.com
Versor Investments LP Acquires Shares of 2,780 iRhythm Technologies, Inc. (NASDAQ:IRTC) - MarketBeat
iRhythm technologies CEO sells $885,931 in stock By Investing.com - Investing.com India
iRhythm Technologies, Inc. (NASDAQ:IRTC) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World
LAWSUIT FILED: Block & Leviton LLP Reminds Investors that it Has Filed a Lawsuit Against iRhythm Technologies, Inc. for Securities Fraud; Investors Who Lost Money Should Contact the Firm - ACCESS Newswire
iRhythm technologies EVP sells $187,737 in stock By Investing.com - Investing.com South Africa
iRhythm technologies CFO sells $254,630 in stock By Investing.com - Investing.com Canada
iRhythm technologies CFO sells $254,630 in stock - Investing.com
1.79%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):